AOD-9604

weight loss

Advanced Obesity Drug 9604

Mechanism of Action

A modified fragment of human growth hormone (amino acids 177-191). Stimulates lipolysis and inhibits lipogenesis without GH's growth-promoting or diabetogenic effects.

Common Doses

300mcg

1x dailysubcutaneous

500mcg

1x dailyoral

Common Protocols

Fat Loss8-12 weeks

300mcg subcutaneous daily, morning on empty stomach

Safety Notes

Completed Phase 2 trials for obesity. Generally well-tolerated. Not FDA-approved.

Legal Status

United States

Category 1 (pending)

Australia

Schedule 4

United Kingdom

Unregulated (RUO)

Ready to track this peptide?

Start Experiment

This information is for educational purposes only. N1X does not recommend, endorse, or facilitate access to any substance. Always consult a qualified healthcare provider before starting any protocol.